|
|
|
| Consideration of Several Problems in Clinical Application of Prostaglandin Analogues in Lowering Intraocular Pressure |
| Yumei Yang1, 2, Qi Zhang1, Xin Liu1, Min Chen1, Yuanbo Liang3, Kaijun Wang1 |
| 1Eye Center, the Second Affliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China2Department of Ophthalmology, Shaoxing Shangyu People's Hospital, Shaoxing 312300, China3Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China |
|
|
|
| Guide |
|
|
Abstract Nowadays, prostaglandin analogues (PGAs) have been increasingly used in lowering intraocular pressure, and recommended as the frst-line drugs for primary open angle glaucoma (POAG) in the latest glaucoma guidelines. In order to enhance the understanding of new guidelines and promote the standardized application of PGAs, experts held a panel discussion during the West Lake Glaucoma Conference in Hangzhou, Zhejiang Province, in January 2021, analyzing the issues in PGAs clinical practice with a large number of references. In that meeting, opinions and recommendations for PGAs medication were put forward on the basis of the research progress of the mechanism for lowering intracular pressure, as well as PGAs clinical trials in special cases.
|
|
Received: 12 January 2022
|
|
|
| Fund: |
|
Corresponding Authors:
Kaijun Wang, Eye Center, the Second Affiliated Hospital, School of Medicine,Zhejiang University, Hangzhou 310009, China (Email: ze_wkj@zju.edu.cn
|
|
|
|
|
|
|
